Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2021-02-23 Interim / Quarterly Rep…
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
2021 Half Year Financial Results 7 pages 379.5KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Nanosonics 2021 half-year financial results' and discusses the half year ended 31 December 2020. It contains detailed financial data including revenue, profit, cash flow, and segment performance for the half year period. The text includes comprehensive financial tables and analysis of business trends and outlook for the half year. This matches the characteristics of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year and contains substantive financial data and analysis. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or summary. Therefore, the appropriate classification is IR (Interim / Quarterly Report). H1 2021
2021-02-23 English
2021 Half Year Financial Results Investor Presentation 29 pages 4.3MB
Regulatory Filings
2021-02-23 English
Ceasing to be a substantial holder for NAN 3 pages 282.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001. It details changes in relevant interests and voting securities of a substantial holder, Selector Funds Management Limited, including dates and nature of changes. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the Major Shareholding Notification category. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2021-02-22 English
Notification of H1 FY21 financial results and investor call 1
Report Publication Announcement Classification · 95% confidence The document is a short announcement (1295 characters) notifying the market about the upcoming release of the company's Half Year financial results for the period ending 31 December 2020. It also invites investors to a conference call on the same day as the results release. There is no actual financial data or detailed report content included, only a notification of the event and report release. According to the 'MENU VS MEAL' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2021-02-16 English
Appendix 3G 14 pages 264.9KB
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Nanosonics Limited regarding the issue of performance rights and options under an employee incentive scheme. It includes detailed information about the number and type of securities issued, recipients (including key management personnel), and references to Appendix 3G, which is a standard form for notifying the ASX of equity securities issued. The content is regulatory in nature, focused on equity issuance and compliance with ASX listing rules, rather than a financial report or earnings release. It is not a report or presentation but a formal notification of a capital change event. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice, but a substantive filing about capital changes.
2021-01-26 English
Change of Director's Interest Notice 3 pages 127.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings of a company director, including performance rights, options, and ordinary shares. The document is a formal notification of insider share transactions by a director, which aligns with the definition of Director's Dealing filings. There is no financial report, earnings data, or management discussion present. The document length is 4624 characters, which is consistent with a detailed insider transaction notice rather than a full financial report or announcement. Therefore, the correct classification is Director's Dealing (DIRS).
2021-01-26 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.